4
Changes in Ownership
Protara Therapeutics, Inc. Filed Acc 0001209191-20-043742
Options or other derivatives
- Director acquired 26,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Flannelly Barry P · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-07-23 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +18,000 | 18,000 | D |
| 2020-07-23 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +8,250 | 26,250 | D |
Loading xslF345X03/doc4.xml…